Barriers and facilitators of tuberculosis treatment among immigrants: an integrative review.

Publication date: Dec 18, 2024

Migration, as an important social determinant in the field of health, plays a crucial role in the non-eradication of tuberculosis worldwide. Therefore, it is essential to identify the factors related to tuberculosis treatment in immigrants to effectively combat this disease. However no comprehensive study has focused on this issue. Therefore, this study was conducted using an ecological approach to identify the barriers and facilitators of tuberculosis treatment in immigrants. This qualitative study utilized an integrative literature review. Studies were searched without time restrictions in database such as MEDLINE, Institute for Scientific Information (ISI), Google Scholar, Scopus, and EMBAS, as well as internal databases like Scientific Information Database and Magiran. The findings of 100 studies that met the inclusion criteria were analyzed using the conventional content analysis method based on the ecological approach. In general, the aforementioned codes were placed into four main categories, including individual factors (i. e., biological factors, psychological factors, behavioral factors, patient knowledge, factors related to tuberculosis, and economic factors), interpersonal factors (i. e., communication with the treatment team and family-related factors), factors related to health service provider centers (i. e., medical facilities), and extra-organizational factors (i. e., social factors and health policies). The findings of the present study show that treating tuberculosis in immigrants is a complex phenomenon influenced by several factors. Therefore policymakers and healthcare providers should take a more comprehensive look at the factors affecting treatment in this group of patients to plan and implement more effective interventions.

Open Access PDF

Concepts Keywords
Google Content analysis
Healthcare Ecological approach
Policymakers Emigrants and Immigrants
Tuberculosis Health Services Accessibility
Worldwide Humans
Immigrant
Qualitative Research
Treatment
Tuberculosis
Tuberculosis

Semantics

Type Source Name
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease IDO role
drug DRUGBANK Methionine
pathway REACTOME Reproduction
drug DRUGBANK L-Phenylalanine
drug DRUGBANK Coenzyme M
disease MESH emergency
disease MESH violence
disease IDO country
disease MESH infection
disease IDO host
disease MESH recurrence
drug DRUGBANK Trestolone
disease IDO process
drug DRUGBANK Serine
disease MESH substance abuse
disease MESH comorbidity
drug DRUGBANK Indoleacetic acid
drug DRUGBANK Ethanol
disease MESH unemployment
disease MESH loneliness
disease MESH infectious diseases
drug DRUGBANK Nonoxynol-9
disease MESH Respiratory Diseases
disease MESH Lung Diseases
disease MESH pulmonary tuberculosis
disease MESH latent tuberculosis
disease MESH treatment failures
disease IDO intervention
drug DRUGBANK Water
disease MESH anxiety
disease MESH dementia
disease MESH AIDS
disease IDO facility
drug DRUGBANK Isoniazid
drug DRUGBANK L-Aspartic Acid
drug DRUGBANK Rifampicin
drug DRUGBANK Spinosad
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH treatment delay
drug DRUGBANK Tretamine
disease MESH Health Services Accessibility

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *